Registered entities
Curi Bio, Inc.
Reg. No. 473278142United States
Innovation
10 patent families (4 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities, Operations & transport; filing pace accelerating. Cited 118 times.
| Year | Filings |
|---|---|
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 2 |
Social engagement
Social engagement: 9.7K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Dynamk Capital, Dream CIS.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 29% |
| Private equity | 1 | 14% |
| Other / undisclosed | 4 | 57% |
Recent activity
2 Jul 2026
Event
Joint webinar with Thomas Leahy, PhD from Curi Bio and Nicholas Coungeris, PhD from 28bio on CNS disease modeling and screening
1 Jul 2026
Event
Engineering the Future of Drug Discovery: A Deep Dive into 3D Human Muscle Tissues
30 Jun 2026
Event
23rd ESTIV International Congress